` N4CN (Paratek Pharmaceuticals Inc) vs DAX Index Comparison - Alpha Spread

P
N4CN
vs
D
DAX Index

Over the past 12 months, N4CN has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +22% growth.

Stocks Performance
N4CN vs DAX Index

Loading
N4CN
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
N4CN vs DAX Index

Loading
N4CN
DAX Index
Difference
www.alphaspread.com

Performance By Year
N4CN vs DAX Index

Loading
N4CN
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Paratek Pharmaceuticals Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Paratek Pharmaceuticals Inc
Glance View

Market Cap
115.9m EUR
Industry
Pharmaceuticals

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. The company is headquartered in Boston, Massachusetts and currently employs 207 full-time employees. The company went IPO on 2006-05-10. The firm is focused on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use. The firm's lead product, NUZYRA (omadacycline), is an oral and intravenous antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia (CABP), and acute skin and skin structure infections (ABSSSI), caused by susceptible pathogens. Omadacycline is used in the emergency room, hospital, and community care settings. Its second product, SEYSARA (Sarecycline), is an oral therapy for the treatment of moderate to severe acne vulgaris.

N4CN Intrinsic Value
Not Available
P
Back to Top